Checkpoint inhibitor is active against large cell neuroendocrine carcinoma with high tumor mutation burden-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Checkpoint inhibitor is active against large cell neuroendocrine carcinoma with high tumor mutation burden

Published:2017-09-19 Issue:1 Volume:5 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Wang Victoria E.,Urisman Anatoly,Albacker Lee,Ali Siraj,Miller Vincent,Aggarwal Rahul,Jablons David

Funder

Damon Runyon Cancer Research Foundation

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-017-0281-y.pdf

Reference23 articles.

1. Naidoo J, et al. Large cell Neuroendocrine carcinoma of the lung: Clinico-pathologic features, treatment, and outcomes. Clinical lung cancer. 2016;17:e121–9. doi: 10.1016/j.cllc.2016.01.003 .

2. Veronesi G, et al. Large cell neuroendocrine carcinoma of the lung: a retrospective analysis of 144 surgical cases. Lung Cancer. 2006;53:111–5. doi: 10.1016/j.lungcan.2006.03.007 .

3. Le Treut J, et al. Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study. Ann Oncol : official J European Soc Med Oncol. 2013;24:1548–52. doi: 10.1093/annonc/mdt009 .

4. Rekhtman N, et al. Next-generation sequencing of pulmonary large cell Neuroendocrine carcinoma reveals small cell carcinoma-like and non-small cell carcinoma-like subsets. Clin Cancer Res : an Official J Am Assoc Cancer Res. 2016;22:3618–29. doi: 10.1158/1078-0432.ccr-15-2946 .

5. Miyoshi T, et al. Genomic profiling of large-cell Neuroendocrine carcinoma of the lung. Clin Cancer Res : an Official J Am Assoc Cancer Res. 2017;23:757–65. doi: 10.1158/1078-0432.ccr-16-0355 .

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroendocrine Neoplasms;Pulmonary Pathology;2025

2. Bronchoscopic Interventional Therapy Combined With Pembrolizumab in the Treatment of Pulmonary Large Cell Neuroendocrine Carcinoma: A Case Report;The Clinical Respiratory Journal;2024-09

3. Mutational analysis of pulmonary large cell neuroendocrine carcinoma: APC gene mutations identify a good prognostic factor;Lung Cancer;2024-06

4. Primary pure large cell neuroendocrine carcinoma of the urinary bladder: a case report and literature review;Frontiers in Oncology;2024-03-11

5. Immunotherapy for Neuroendocrine Neoplasms;Neuroendocrine Tumours;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3